Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Wednesday that its total revenues for the fourth quarter of 2019 rose about 23 percent, driven by continued growth in its product and services business.

For the three months ended Dec. 31, 2019, total revenues rose to $36.9 million from $30.0 million in Q4 2018, beating the average Wall Street estimate of $34.5 million and exceeding a preliminary estimate this January of $36.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.

Mar
17
Sponsored by
IONPath

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.